ArticleHepatology communications2022

Glycine-β-muricholic acid antagonizes the intestinal farnesoid X receptor-ceramide axis and ameliorates NASH in mice.

Jie Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.